In the midst of an opioid epidemic that is killing nearly 100 people every day, the FDA has taken action against a natural medical food that offers patients an alternative to opioids. Last November, the FDA posted a warning on its website concerning Limbrel, a medical food marketed by Primus Pharmaceuticals for the management of osteoarthritis. Then, in December, the agency recommended that Primus voluntarily recall Limbrel. The stated reason for the warning is that the FDA is investigating serious adverse events involving Limbrel. In a letter to Primus, the FDA states that 194 adverse event reports for Limbrel were received between 2007 and 2017—about 20 a year. Consider that NSAIDs (non-steroidal anti-inflammatory drugs), an alternative treatment for arthritis, cause approximately 107,000 hospitalizations every year, along with an estimated 16,500 deaths among arthritis patients alone. Limbrel’s two main ingredients are Chinese skullcap and catechin, a flavonol and antioxidant found in blueberries and other fruits, as well as brewed tea, chocolate, and red wine. Chinese skullcap has been used safely in traditional Chinese medicine for many, many years.
Ginger is one of the most versatile food-spice-herbs known. Ginger is a fundamental herbal treatment among among Traditional Chinese Medicine, Ayurveda, Traditional Thai Medicine, Japanese Kampo Medicine and various others. An accumulation of studies and chemical analyses in 2000 determined that ginger has at least 477 active constituents. Finally, researchers are getting wind that ginger can treat numerous ailments – as purported in these traditional medicines thousands of years ago. In fact, in the past five years, a number of human clinical studies have shown some of ginger’s amazing properties to treat and prevent various disease conditions—just as predicted by the ancient medicines.
Research from Australia’s Edith Cowan University has confirmed an ancient treatment – that osteoarthritis pain and mobility is reduced with the application of ginger root topically. The researchers recruited 20 adults between the ages of 35 and 90 years old – average age of 64 years old. All of the volunteers had been diagnosed with osteoarthritis. 85% of the patients had osteoarthritis of the knees and/or hips. The researchers randomly divided the patients into two groups, and treated half of them with a ginger (Zingiber officinalis) compress, and half with a ginger transdermal patch – a patent-pending product from New Zealand. The patients applied the patch or compress daily. They were monitored weekly with a Health Assessment Questionnaire throughout the 24 week study. The patients in both groups experienced significant improvement in pain, fatigue, well-being and mobility after only seven days, and this improvement increased through the study. Researchers concluded that “This pilot study suggests ginger therapy using both the ginger compress and ginger patch has the potential to relieve symptoms and increase independence for people with osteoarthritis.”
If you are among the millions of Americans suffering from joint pain and arthritis, there's good news about a favorite summer treat. According to research from Oregon Health & Science University, tart cherries help reduce the chronic inflammation that leads to pain. In fact, the Oregon researchers declared that tart cherries have the "highest anti-inflammatory content of any food" and can help osteoarthritis patients manage their condition.
by Sayer Ji
New research flies in the face of a new theory that statin drugs, used to lower cholesterol, may be of value in those suffering from osteoarthritis. To the contrary, statin drugs are likely contributing to the epidemic of knee osteoarthritis in exposed populations.
Symptomatic knee osteoarthritis is quite common in people older than 40 […]
by Dr. Mercola
A study shows that a formulation of curcumin can relieve pain and increase mobility in patients with osteoarthritis. It can also reduce a series of inflammatory markers.
100 patients with osteoarthritis were divided in two groups — the first group was given the “best available treatment” and the second group was given the […]